US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pfenex

12.75

0.0000

Volume:- -

Turnover:- -

Market Cap:437.28M

PE:-70.90

High:12.75

Open:12.75

Low:12.75

Close:12.75

52wk High:14.00

52wk Low:5.26

Shares:34.30M

Float Shares:31.15M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1798

EPS(LYR):0.0335

ROE:-9.22%

ROA:-4.95%

PB:5.92

PE(LYR):380.85

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Pfenex

Exchange:

AMEX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.pfenex.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidate include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis. The company also develops PF743, a recombinant crisantaspase; PF745, a recombinant crisantaspase with half-life extension technology; and PF810, a peptide based next generation therapeutic which is in preclinical development, as well as offers sparX-1 (PF753) and sparX-2 (PF754). In addition, it has license and supply agreements for CRM197, a non-toxic mutant of diphtheria toxin. Pfenex Inc. is headquartered in San Diego, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PFNX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PFNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFNX\",,,,,undefined,":{"symbol":"PFNX","market":"US","secType":"STK","nameCN":"Pfenex","latestPrice":12.75,"timestamp":1601582400000,"preClose":12.75,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":31151972,"shares":34296593,"eps":-0.179841,"marketStatus":"Delisted","change":0,"latestTime":"02-23 12:38:27 EST","open":12.75,"high":12.75,"low":12.75,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.179841,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771880400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1406174400000,"exchange":"AMEX","adjPreClose":12.75,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFNX\",,,,,undefined,":{"symbol":"PFNX","floatShares":31151972,"roa":"-4.95%","roe":"-9.22%","lyrEps":0.033478,"shares":34296593,"dividePrice":0,"high":12.75,"amplitude":0,"preClose":12.75,"low":12.75,"week52Low":5.26,"pbRate":"5.92","week52High":14,"institutionHeld":0,"latestPrice":12.75,"eps":-0.179841,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.179841,"open":12.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PFNX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-10-01","symbol":"PFNX","reason":null,"defaultRemindTime":1601559000000,"announcedDate":"2020-09-30","type":"delisting","dateTimestamp":1601524800000},{"market":"US","date":"2020-08-06","symbol":"PFNX","fiscalQuarterEnding":"2020/06","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1596686400000,"reportTimeType":"post","actualEps":-0.3},{"date":"2020-05-07","symbol":"PFNX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2020/03","expectedEps":-0.26,"defaultRemindTime":1588881600000,"name":null,"time":"Post Market","dateTimestamp":1588824000000,"actualEps":null},{"market":"US","date":"2020-03-11","symbol":"PFNX","fiscalQuarterEnding":"2019/12","expectedEps":0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1583899200000,"reportTimeType":"post","actualEps":0.29},{"market":"US","date":"2019-11-07","symbol":"PFNX","fiscalQuarterEnding":"2019/09","expectedEps":0.09,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1573102800000,"reportTimeType":"post","actualEps":0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PFNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PFNX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PFNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PFNX","date":"2020-09-30","current":-70.895958,"percent":0.342857,"low":-110.163438,"twenty":-92.085335,"median":-14.688423,"eighty":-10.720523,"high":313.906954,"avg":-2.60925,"sd":99.098569,"marketCap":437624526},"quantilePoints":[],"updateTime":1771854999256},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.pfenex.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidate include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis. The company also develops PF743, a recombinant crisantaspase; PF745, a recombinant crisantaspase with half-life extension technology; and PF810, a peptide based next generation therapeutic which is in preclinical development, as well as offers sparX-1 (PF753) and sparX-2 (PF754). In addition, it has license and supply agreements for CRM197, a non-toxic mutant of diphtheria toxin. Pfenex Inc. is headquartered in San Diego, California.","exchange":"AMEX","name":"Pfenex","nameEN":"Pfenex"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PFNX\",market:\"US\",,,undefined,":null}}